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We have analyzed the role of terminal sequences of a defective interfering (DI) particle RNA of vesicular stomatitis virus
(VSV) in replication. A series of internal deletion mutants of DI cDNA was generated to obtain DI genomic RNAs that differed
from one another by the presence of different lengths of 3*-terminal and/or 5*-terminal sequences. Analyses of the mutant
RNAs for their ability to replicate in cells transfected with the corresponding plasmids suggested that distinct regions at
the termini of DI RNA are important for RNA replication. Region I, encompassing nucleotides 1–24, is absolutely required
for replication since DI RNA genomes lacking any part of this region failed to replicate. Region II, spanning nucleotides 25–
45, is not essential for replication but it functions as an enhancer of replication in that the presence of these specific
sequences confers high efficiency of replication to the template. Deleting these specific sequences from both termini of DI
RNA but maintaining the length of terminal complementarity as seen in wild-type DI RNA resulted in a template that replicated
poorly (about 20-fold less efficiently). Furthermore, insertion or substitution of these sequences into the 3*-terminus of a
VSV minigenome resulted in a template that replicated more efficiently (at least 4-fold to as high as 15-fold) than the parental
minigenome. These results strongly support the conclusion that the presence of specific sequences rather than the extent
of complementarity at the termini of DI RNA is a major determinant of the efficiency of replication. The presence of the
specific sequences at the 3*-terminus of both genomic and antigenomic DI RNAs may explain in part the replicative
dominance of DI RNA over the full-length VSV genome which contains these sequences only at the 3*-terminus of the
antigenome. q 1997 Academic Press
INTRODUCTION mRNAs. Following translation of the mRNAs to generate
the viral proteins, the nucleocapsid template undergoes
Vesicular stomatitis virus (VSV), the prototypic rhab- replication to produce a full-length complementary copy
dovirus, is a member of the family Rhabdoviridae within of the genome (called the antigenome) which is also
the recently classified superfamily Mononegavirales encapsidated by the N protein. It has been proposed that
(Bishop and Pringle, 1995). All members of Mononegalo- interaction of the N protein with the nascent RNA chain
virus superfamily contain a nonsegmented negative- plays a major role in the switch from transcription to
strand RNA genome of approximately 11,000 to 19,000 replication (Blumberg et al., 1981; Wertz et al., 1986). The
nucleotides. The genome of VSV is 11,161 nucleotides antigenomic nucleocapsid serves in turn as the template
(Rose and Schubert, 1986) and contains five transcription for synthesis of progeny nucleocapsids for packaging
units coding for the five structural proteins of the virion into virions as well as for further rounds of transcription
that play key roles in the viral replicative cycle. Two small and replication. At later stages of infection, a large ex-
basic proteins are also expressed from the phosphopro- cess of genomic nucleocapsids over antigenomic nu-
tein (P) mRNA in infected cells (Peluso et al., 1996) but cleocapsids has been shown to be present in cells in-
they do not appear to play any major role in the replica- fected with VSV as well as other negative-strand RNA
tive cycle of the virus (Kretzschmar et al., 1996). viruses (Kolakofsky and Bruschi, 1975; Schincariol and
The genomic RNA is tightly wrapped around by the Howatson, 1972; Simonsen et al., 1979; Soria et al., 1974).
nucleocapsid protein (N) to form the nucleocapsid struc- Whether the asymmetric levels of the two RNAs are a
ture. The polymerase complex of the large protein (L) reflection of the relative strengths of the promoters for
and the phosphoprotein (P) is associated with the nu- synthesis of genomic and antigenomic RNAs is not clear
cleocapsid structure to form the active template for tran- at the present time.
scription and replication (Emerson and Yu, 1975; Ban- To gain understanding of the replication signals within
erjee, 1987). The negative-sense nucleocapsid template the VSV genome, we have been studying a defective
first directs transcription to generate subgenomic interfering (DI) particle (DI-T) of VSV which is a member
of the copy-back family of DI particles generated by a
high multiplicity infection of cells in culture by VSV (Leam-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (305) 243-4623. E-mail: apattnai@mednet.med.miami.edu. son and Reichman, 1974). The RNA genome of the DI-T
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FIG. 1. (A) Organization of VSV and DI particle genome. The genes coding for the five VSV proteins are shown (not to scale). le and tr represent
the leader and trailer regions, respectively, of the VSV genome. DL in DI genome represents part of the L gene. tr* at the 3*-terminus of the DI
genome represents 45 nucleotides of complementary sequences from the 5*-terminus of the DI genome. (B) Schematic representation of pDI and
various mutants of pDI. The DI cDNA in pDI plasmid is 2209 nucleotides long (Pattnaik et al., 1992). Construction of the mutants is described under
Materials and Methods. Transcription in vitro or in transfected cells by T7 RNA polymerase from each pDI construct generates negative-sense DI
RNA with the deletion of nucleotides at either terminus or at both termini. Synthesis of each transcript is initiated at the T7 RNA polymerase
promoter (f10) and terminated at the T7 RNA polymerase terminator (Tf), resulting in DI RNA whose 5*-terminus contains two extra guanosine
residues and whose 3*-terminus is identical in nucleotide sequence to that of the authentic DI RNA due to autolytic cleavage of the primary transcript
by the hepatitis delta virus ribozyme (d). (C) Schematic representation of p9BN. Construction of these plasmids is described under Materials and
Methods. Upon transcription by T7 RNA polymerase, the plasmid p9BN generates an antigenomic VSV RNA (9BN) 1618 nucleotides long. In cells
cotransfected with p9BN and plasmids coding for VSV proteins N, P, and L, the 9BN antigenomic RNA can undergo replication to generate the
genomic RNA 9BN(0). The 9BN(0) RNA can subsequently be replicated to produce 9BN(/) RNA and can also be transcribed to synthesize a
chimeric mRNA (NDL mRNA) approximately 1470 nucleotides long (excluding the poly(A) tail) containing the entire coding sequence of the N gene
and a part of the L gene. le* and tr* represent complementary sequences of leader and trailer regions of the VSV genome. Tha primary sequence
of the first 50 nucleotides of the 5*-terminus of the antigenomic RNAs generated from p9BN and the mutant plasmids are shown at the bottom of
the figure. Inserted or substituted sequences are boxed.
particle is 2208 nucleotides long (Fig. 1A). It contains at plement of the first 45 nucleotides of the 5*-terminus of
the VSV genome (Meier et al., 1984). The genome of DI-its 5*-terminus 2163 nucleotides from the 5*-terminus of
the VSV genome and at the 3*-terminus an inverted com- T thus contains only a part of the L gene and lacks the
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genetic information to code for any of the viral proteins. MEM supplemented with 5% FBS. Stocks of VSV (Indiana
serotype, San Juan strain) and DI-T particles (LeamsonHowever, the DI-T genomic RNA replicates far more effi-
ciently than the full-length VSV genome in cells co-in- and Reichman, 1974; Stamminger and Lazzarini, 1979)
were prepared as described previously (Pattnaik andfected with VSV and DI-T particles or in cells expressing
VSV proteins from transfected plasmids (Pattnaik and Wertz, 1990). Stocks of recombinant vaccinia virus (vTF7-
3) carrying the bacteriophage T7 RNA polymerase geneWertz, 1990).
Previously, we established a reverse genetic system (Fuerst et al., 1986) were prepared in BHK-21 cells and
infectivity titers were determined by plaque assay in 143Bfor the VSV DI particle in which replication of DI-T geno-
mic RNA, assembly, and budding of infectious particles cells.
entirely from cDNA clones were achieved (Pattnaik et al.,
Expression plasmids1992). In this system, negative-sense DI RNA synthesized
from a specialized transcription plasmid (pDI) was repli-
Plasmids pN, pP, pL, pM, and pG carrying the genes
cated by the VSV proteins N, P, and L expressed by
for the VSV nucleocapsid protein (N), the phosphoprotein
cotransfection of the plasmids carrying the correspond-
(P), the large protein (L), the matrix protein (M), and the
ing genes. In cells expressing all five VSV proteins, the
glycoprotein (G), respectively, under the control of the T7
DI RNA was replicated and packaged into particles and
RNA polymerase promoter have been described pre-
released from these cells as infectious DI particles. Us-
viously (Pattnaik and Wertz, 1990, 1991). The plasmid
ing this reverse genetic system, we recently showed that
pDI, carrying a cDNA copy of the DI-T genomic RNA
the signals necessary for RNA encapsidation, replication,
under the control of the T7 RNA polymerase promoter,
and packaging into infectious DI particles are contained
has been described (Pattnaik et al., 1992). In transfected
within the 5*-terminal 36 nucleotides and the 3*-terminal
cells or in vitro, pDI generates a negative-sense RNA
51 nucleotides of the DI genomic RNA (Pattnaik et al.,
transcript with two extra G nucleotides at the 5*-terminus;
1995). To gain understanding of the factors affecting the
however, the 3*-terminus of the transcript which is gener-
efficiency of replication of DI RNA, Wertz et al. (1994)
ated due to autolytic cleavage by the hepatitis delta virus
showed that the extent of terminal complementarity is a
ribozyme (Fig. 1B) is identical in nucleotide sequence to
major determinant of the efficiency of replication. How-
that of the DI-T genomic RNA. The plasmid p9BN was
ever, in a similar study using Sendai virus (another non-
generated by ligation of a PCR-amplified fragment con-
segmented negative-strand RNA virus), it has been dem-
taining only the N gene coding sequences into the
onstrated recently that specific sequences, rather than
unique BglII site of plasmid p9B (Fig.1C). p9B is a plasmid
the complementarity at the termini, modulate replication
that contains a cDNA fragment corresponding to the first
efficiency of Sendai virus and its DI particle RNAs (Tap-
63 nucleotides of the 5*-terminus of VSV antigenomic
parel and Roux, 1996).
RNA linked by a unique BglII site to a cDNA fragment
To identify and define the signal(s) necessary for repli-
corresponding to 268 nucleotides at the 3*-terminus of
cation of DI RNA of VSV, we generated a panel of mutants
VSV antigenomic RNA in the specialized transcription
of pDI that encode DI RNAs with deletions and substitu-
vector described previously (Pattnaik et al., 1992). Tran-
tions at the termini. Results obtained from the analyses
scription from p9BN by T7 RNA polymerase and subse-
of these mutants suggest that the nucleotides 1 to 24 at
quent cleavage by the ribozyme generates a positive-
the 3*-terminus of the genomic and antigenomic DI RNA
sense VSV antigenomic RNA that is 1618 nucleotides
contain the minimal replication signals that are required
long.
for replication of DI RNA. However, nucleotides 25 to
45 at the 3*-terminus contain regulatory sequences that Construction of mutants
significantly enhance DI RNA replication. These specific
sequences, when transferred to the 3*-terminus of a VSV An initial series of progressive deletion mutants of pDI
was generated by linearizing pDI at the unique PpuMIminigenomic RNA template, enhanced VSV minigenomic
RNA replication. We also show that the length of terminal site located at position 145 from the 3*-terminus of DI
cDNA (Fig.1B). The linear plasmid was then subjected tocomplementarity does not appear to play a major role in
efficient replication of DI RNA. exonuclease III digestion for various length of time. The
DNA was subsequently treated with mung bean
nuclease to generate blunt ends. Following ligation, theMATERIALS AND METHODS
DNA was used to transform competent bacterial cells
Cells and viruses
(Escherichia coli DH5a). Individual colonies were
screened for appropriate deletions by nucleotide se-Baby hamster kidney (BHK-21) cells were maintained
as monolayer cultures in Eagle’s minimal essential me- quencing. Clones containing the plasmids pDI89, pDI38,
pDI31, and pDI13 were identified in this manner. Thesedium (MEM) containing 7.5% heat-inactivated fetal bovine
serum (FBS). Thymidine kinase-negative human 143B clones retained 89, 38, 31, and 13 nucleotides, respec-
tively, from the 3*-terminus of DI cDNA sequence (Fig.cells were also maintained as monolayers in Eagle’s
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1B). The plasmid pDI5*30 was also generated in a similar Virus infections and DNA transfections
manner and it contained deletion of sequences at the
BHK-21 cells grown in 60-mm plates or 35-mm 6-well
5*-terminus of DI cDNA.
plates to about 90% confluency were infected with the
Several site-specific deletion mutants of pDI were gen- recombinant vaccinia virus (vTF7-3) at a multiplicity of
erated by using the Transformer mutagenesis kit from infection (m.o.i.) of 10 PFU per cell. After 45 min of virus
Clontech Laboratories. It is based on the method of Deng adsorption at 377, inoculum was removed; the cells were
and Nickoloff (1992) and uses double-stranded DNA as washed twice with Dulbecco’s modified MEM (DMEM)
template. Plasmids pDI45, pDI3*30, pDI3*/5*30, and pDIS without serum and transfected with various plasmid
(Fig. 1B) were generated in this manner. The plasmid DNAs using lipofectin (GIBCO/BRL, Bethesda, MD) ac-
pDI45 encodes DI RNA with deletion of nucleotides 46 cording to manufacturer’s specifications. At 4–5 hr post-
to 60 from the 3*-terminus; plasmid pDI3*30 encodes DI transfection, medium from transfected cells was re-
RNA with deletion of nucleotides 31 to 45 from the 3*- moved, cells were washed twice with DMEM containing
terminus, and plasmid pDI3*/5*30 encodes DI RNA with 2% FBS, and incubated with appropriate volume of the
deletion of nucleotides 31 to 45 from both termini. The same medium. For DI particle budding experiments, 6
plasmid pDIS generates an RNA that lacks sequences mg of pN, 4 mg of pP, 2 mg of pL, 5 mg of pM, 5 mg of
31 to 45 from both termini; however, complementary se- pG, and 5 mg of pDI or mutant pDI plasmids were used
quences from nucleotides 46 to 60 from the 3*-terminus for 60-mm plates. For RNA replication assays, 3 mg of
were inserted into the 5*-terminus at nucleotide posi- pN, 2 mg of pP, 1 mg of pL, and 5 mg of pDI or mutant
tions 31 to 45. Thus, DIS RNA maintains 45 nucleotides pDI plasmids or 0.5 ml of culture fluids (out of 1.5 ml)
of complementarity at the termini but lacks the sequence from budding experiments were used.
from nucleotides 31 to 45. A series of deletion mutants
spanning the first 30 nucleotides at the termini of DI Radiolabeling and analysis of RNA
cDNA was also generated in this manner. These plas-
To analyze DI particle RNA replication, transfected
mids were designated pDID3*1-6, pDID3*7-12, pDI-
cells were exposed to [3H]uridine (25 mCi/ml) in the ab-
D3*13-18, pDID3*19-24, and pDID3*25-30, which con-
sence or in the presence of 15 mg of actinomycin D per
tained deletions of nucleotides 1 to 6, 7 to 12, 13 to 18, milliliter. Labeling of RNA was performed for different
19 to 24, and 25 to 30 at the 3*-terminus, respectively, lengths of time (see figure legends). After labeling, cells
and pDID5*1-6, pDID5*7-12, pDID5*13-18, pDID5*19-24, were washed in cold PBS and cytoplasmic extracts were
and pDID5*25-30, which contained the deletions at the prepared in lysis buffer as described previously (Pattnaik
5*-terminus of the encoded DI RNAs. and Wertz, 1990). Replicating RNAs in nucleocapsids
Insertion mutants p9BN31-45i and p9BN25-45i were were immunoprecipitated by polyclonal anti-VSV antibod-
generated by inserting complementary nucleotides 31– ies. RNAs were recovered from immunoprecipitated nu-
45 or 25–45 from the 3*-terminus of VSV antigenomic cleocapsids by phenol–chloroform extraction as de-
RNA into the 5*-terminus of VSV antigenomic RNA imme- scribed before, resolved by electrophoresis in agarose –
diately after nucleotides 30 or 24, respectively. Substitu- urea gels (Lerach et al., 1977), and detected by fluorogra-
tion mutant p9BN31-45s was generated similarly by sub- phy (Laskey, 1980).
stituting complementary nucleotides 31–45 from the
3*-terminus of the VSV antigenome in place of the corre- RESULTS
sponding sequences at the 5*-terminus of the VSV anti-
The terminal 24 nucleotides of DI RNA contain all thegenome. All these mutants were generated using the
signals that are necessary and sufficient forPCR ‘‘megaprimer’’ method (Sarkar and Sommer, 1990).
replication of DI RNABriefly, an internal forward ‘‘mutant’’ primer containing the
desired changes and a reverse primer containing the Previous data from our laboratory using a series of
FspI site of the vector were used to amplify a fragment internal deletion mutants of pDI suggested that the sig-
by PCR using p9BN as template. The fragment was then nals necessary for RNA encapsidation, replication, and
used as a megaprimer in a second round of PCR amplifi- packaging into infectious DI particles are contained
cation using p9BN as template along with another flank- within the 5*-terminal 36 nucleotides and the 3*-terminal
ing primer containing the 3*-terminal BglII site (at position 51 nucleotides of the DI RNA genome (Pattnaik et al.,
210 of VSV genome). The second PCR product was di- 1995). In order to define the minimal signal for replication
gested with BglII and FspI and subcloned into the corre- of DI RNA, we initially generated a series of deletion
sponding sites of the plasmid p9BN. All the mutants were mutants of pDI with progressively fewer nucleotides at
confirmed by DNA sequencing (Sanger et al., 1977). Stan- the 3*-terminus of the encoded RNAs (Fig. 1B). The RNAs
dard methods of DNA manipulation and preparation of generated from these mutant pDI templates by T7 RNA
plasmids (Ausubel et al., 1988; Sambrook et al., 1989) polymerase contain 89 (pDI89), 45 (pDI45), 38 (pDI38),
31 (pDI31), or 13 (pDI13) nucleotides from the 3*-terminuswere used.
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genomic (positive-sense, bottom band) RNAs of the DI
particle are resolved as a closely migrating doublet. The
DI13 RNA did not produce infectious particles since no
RNA was detected in the replication assay (Fig. 2A, lane
5). These results suggested that the first 31 nucleotides
at the 3*-terminus of DI RNA contain all the necessary
signals for replication and packaging of DI RNA into parti-
cles. However, it was not clear whether DI13 RNA had
lost all or part of the encapsidation, replication, and/or
packaging signal(s). Furthermore, the levels of replication
of DI38 and DI31 RNAs were significently below that of
DI RNA, whereas DI89 and DI45 RNAs were replicated
at the same level as the DI RNA (Table 1). In addition,
the molar ratios of negative- and positive-sense RNAs
were significantly different for DI38 and DI31 RNAs (Fig.
2A, lane 3 and 4, and Table 1) compared to DI RNA (Fig.
2A, lane 1). Whether this was due to partial loss of the
packaging signal(s), resulting in budding of fewer DI par-
ticles, or due to partial loss of replication signal(s) or
some regulatory sequences, resulting in less efficient
FIG. 2. Assembly and budding of DI particles containing DI RNAs
replication of DI38 and DI31 RNAs, was also not clear.with various deletions. BHK-21 cells in 60-mm plates were infected
To distinguish between these possibilities, we at-with vTF7-3 and transfected with various amounts of all five VSV protein
expression plasmids along with various pDI deletion mutants (as de- tempted to demonstrate replication of the mutant DI
scribed under Materials and Methods). Clarified culture fluids har-
vested from the cells at 24 hr posttransfection were used to superinfect
cells that had been already infected with vTF7-3 and transfected with
TABLE 1plasmids coding for the N, P, and L proteins. Replicating RNAs were
labeled with [3H]uridine (25 mCi/ml) for 6 hr, isolated by immunoprecipi- Relative Levels of Replication of Various Mutant DI RNAs
tation of cell extracts with anti-VSV antibody, analyzed by electrophore-
sis in agarose–urea gels, and detected by fluorography. (A) RNA repli- Molar ratio (expressed as
cation by particles in culture fluids of cells transfected with pDI, pDI89, % of total)b
pDI38, pDI31, or pDI13 is shown in lanes 1 to 5, respectively. Lane 6 Relative levels of
shows RNA replication products directed by DI-T particles. (B) A similar RNA template replication (%)a Genomic Antigenomic
RNA replication analysis with pDI45 (lane 2). The top and bottom bands
of the doublet in the lanes correspond to negative-sense (genomic) DI 100 51 49
and positive-sense (antigenomic) DI RNAs, respectively. DI89 98 52 48
DI45 99 52 48
DI38 22 79 21
DI31 16 85 15of the DI genomic RNA. The mutant pDI plasmids also
DI13 0.5 — —differed from one another in the extent of deletion of the
DI3*30 18 84 16internal sequences which have been shown to have little
DI5*30 18 17 83or no effect on replication of DI RNA (Pattnaik et al.,
DI3*/5*30 5 52 481995).
DIS 6 51 49
The pDI deletion mutants described above were ini-
DID3*1-6 0.5 — —tially used to assay for the ability of the encoded RNAs
DID3*7-12 0.5 — —to be replicated and packaged to generate infectious
DID3*13-18 0.5 — —
particles. Cells were infected with vTF7-3 and subse- DID3*19-24 0.5 — —
quently transfected with plasmids for all five proteins of DID3*25-30 6 nd nd
DID5*1-6 0.5 — —VSV and either pDI or mutant pDI plasmids. Culture fluids
DID5*7-12 0.5 — —from the transfected cells were then assayed for the
DID5*13-18 0.5 — —presence of infectious DI particles by using the RNA
DID5*19-24 0.5 — —
replication assay as described previously (Pattnaik and DID5*25-30 6 nd nd
Wertz, 1990). Results showed that DI89, DI45, DI38, and
Note. nd, not determined.DI31 RNAs replicated and generated infectious particles,
a Average values from two separate experiments. Values0.5 repre-as seen by the presence of replicable RNAs in cells
sent levels below detection.
infected with the particles present in the culture fluids b Data obtained from densitometric scanning of fluorograms shown
(Figs. 2A and 2B). Under the electrophoresis condition, in Figs. 2, 3B, 4, 5, and 6 and taking into consideration of the number
of uridine residues in each templatethe genomic (negative-sense, top band) and the anti-
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presence of actinomycin D would represent products of
RNA replication by VSV RNA polymerase. Cells trans-
fected with plasmids as in Fig. 3A were pretreated with
actinomycin D and subsequently labeled with [3H]uridine
in the presence of actinomycin D. Under these condi-
tions, further RNA synthesis from the transfected plas-
mids by T7 RNA polymerase was completely blocked
(data not shown). In addition, no replication products
were detected in cells that did not express the polymer-
ase proteins (data not shown). Analysis of RNA from
immunoprecipitated nucleocapsids from cells trans-
fected with the pDI plasmids and the plasmids coding
for the VSV proteins N, P, and L showed that both nega-
tive- and positive-sense RNAs were synthesized in cells
transfected with pDI, pDI89, pDI38, and pDI31 plasmids
(Fig. 3B, lanes 1–4). No replication products were de-
tected in cells transfected with pDI13 (Fig. 3B, lane 5),
FIG. 3. Intracellular replication of RNA from pDI deletion mutants. indicating that DI13 RNA lacked all or part of the essential
Cells in 60-mm plates were infected with vTF7-3 and then transfected replication signal(s). The levels of replication of DI38 and
with N, P, and L protein expression plasmids and the pDI mutant
DI31 RNAs (Fig. 3B, lanes 3 and 4, and Table 1) wereplasmids as indicated at the top of each lane. Cells were labeled with
significantly below those of DI and DI89 RNAs (Fig. 3B,25 mCi [3H]uridine per milliliter for 6 hr. Labeled RNAs were recovered
from nucleocapsids immunoprecipitated from cytoplasmic extracts and lanes 1 and 2). Faint but clearly discernible positive-
analyzed by electrophoresis as described in the legend to Fig. 2. (A) strand replication products (indicated by a dot in lanes
Replication of DI RNAs synthesized from plasmids in the absence of 3 and 4 of Fig. 3B) of DI38 and DI31 RNA were visible.
actinomycin D. (B) Replication of RNA generated from the pDI plasmids
The level of replication of DI45 RNA was similar to thatin the presence of acinomycin D. Transfected cells as in (A) were
of DI and DI89 RNAs (data not shown). Furthermore, thepretreated with 15 mg of actinomycin D per milliliter for 45 min at 19
hr posttransfection and subsequently labeled with 25 mCi [3H]uridine relative levels of replication of DI38 and DI31 RNAs were
per milliliter for 6 hr in the presence of the same concentration of similar in the two RNA replication assays (Figs. 2A and
actinomycin D. 3B), thus excluding the possibility that the low levels of
replication seen in Fig. 2, lanes 3 and 4, were due to a
smaller number of infectious particles produced fromRNAs in cells transfected with the plasmids coding for
the VSV proteins N, P, and L, and either pDI or the mutant cells transfected with pDI38 or pDI31 plasmids. The re-
sults indicate that DI38 and DI31 RNAs may have lostplasmids. Cells were labeled with [3H]uridine. Labeled
RNAs present in the immunoprecipitated nucleocapsids sequences that contribute to their efficient replication,
but still retain the minimum necessary signal(s) for repli-were analyzed by electrophoresis in an agarose–urea
gel. Results showed that large amounts of negative- cation.
Taken together, from the results shown in Figs. 2 andsense DI RNAs were synthesized from each of the mutant
plasmids and were encapsidated by the VSV N protein 3, it appears that (i) all the signals necessary for replica-
tion are contained within the first 31 nucleotides at the(upper intense band in each lane of Fig. 3A). Furthermore,
a faster migrating faint band indicated by a dot, presum- 3*-terminus of DI RNA, and (ii) sequences from nucleo-
tides 31 to 45 may contain some regulatory elementsably corresponding to the positive-sense replication
product, was also seen in cells transfected with pDI, that allow increased levels of replication of DI RNA.
To further define the minimal sequence requirementpDI89, pDI38, and pDI31 plasmids (Fig. 3A, lanes 1–4).
No such discernible product that contained RNA from for replication of DI RNA, a series of mutants, each car-
rying a 6-nucleotide deletion spanning the first 30 nucleo-pDI13 transfected cells was visible in lane 5 of Fig. 3A.
Results shown in Fig. 3A thus indicated that all mutant tides at the 3*-terminus of DI RNA, was generated. Since
the terminal 45 nucleotides of DI RNA are complemen-DI RNAs were encapsidated by the N protein and that
all mutant RNAs with the exception of DI13 RNA were tary, we also generated a similar set of 6-nucleotide dele-
tion mutants spanning the first 30 nucleotides at the 5*-possibly replicated by the VSV polymerase proteins.
To further confirm the replicability and determine the terminus of DI RNA. The ability of these mutant RNAs to
be replicated by the VSV proteins in cells transfectedrelative levels of replication of various mutant DI RNAs,
the same experiment was performed but the cells were with the corresponding mutant pDI plasmids in the pres-
ence of actinomycin D was tested. Results of this experi-labeled with [3H]uridine in the presence of actinomycin
D, a drug that inhibits DNA-dependent RNA synthesis ment are shown in Fig. 4. Mutant DI RNAs with deletion
of nucleotides 1 to 6, 7 to 12, 13 to 18, and 19 to 24 atwithout affecting RNA-dependent RNA synthesis by VSV
RNA polymerase. Thus, the RNAs synthesized in the the 3*-terminus were unable to replicate, as seen by
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in the other lanes (Fig. 4, lanes 2–5, and 7–10) and the
presence of only the positive-sense DI RNA (Fig. 4, lane
11) strongly argue against such a possibility and suggest
that these RNAs are the products of RNA replication. The
relative levels of replication of DID3*25-30 and DID5*25-
30 RNAs were almost equal but represented only 5– 7%
of that of the wild-type DI RNA (Table 1). Synthesis of
apparently only negative-sense (Fig. 4, lane 6) or only
positive-sense (Fig. 4, lane 11) RNAs as replication prod-
ucts is most likely due to replication of these RNAs to
generate complementary RNAs at levels below detection.
Thus the results from the above experiments (Figs. 2, 3,
and 4) suggested that the minimal promoter for replica-
tion of DI RNA could be as small as the first 19 nucleo-
tides and is contained within the first 24 nucleotides of
FIG. 4. Replication of DI RNAs with 6-nucleotide deletions at the DI RNA.
termini. Cells in 60-mm plates were infected with vTF7-3 and subse-
quently transfected with plasmids coding for the VSV N, P, and L pro-
teins along with pDI plasmids encoding the deletion mutant DI RNAs Nucleotides 25 to 45 contain regulatory elements that
(as shown at the top of each lane). Transfected cells were pretreated enhance replication of DI particle RNA
with actinomycin D and labeled with [3H]uridine as described in the
legend to Fig. 3. RNAs present in immunoprecipitated nucleocapsids As noted before, two important observations were
were analyzed by agarose–urea gel electrophoresis.
made from the above studies using the pDI deletion mu-
tants: (i) although the levels of RNA replication of DI89
and DI45 RNAs were comparable to those of full-lengththe absence of immunoprecipitable RNA from the cells
transfected with the corresponding mutant plasmids (Fig. DI RNA (Figs. 2, 3, and Table 1), the DI38 and DI31 RNAs
replicated significantly less efficiently (Fig. 2A, lanes 34, lanes 2–5). To determine whether the inability of the
mutant DI RNAs to replicate was due to loss of encapsi- and 4; Fig. 3B, lanes 3 and 4), and (ii) the DI, DI89, and
DI45 RNAs replicated to generate almost equimolardation signal, cells infected with vTF7-3 were transfected
with plasmids encoding wt or mutant DI RNAs and the amounts of both negative- and positive-sense RNAs,
whereas DI38 and DI31 RNAs replicated to generate aN and P plasmids. After labeling with [3H]uridine for 6
hr at 16 hr posttransfection, RNAs from nucleocapsids four- to sixfold molar excess of negative-sense over posi-
tive-sense RNA. This suggested that sequences from nu-immunoprecipitated with anti-VSV antibody were ana-
lyzed by agarose–urea gel electrophoresis. From this cleotides 31 to 45 at the 3*-terminus of the DI genome
may play an important role in upregulating DI RNA repli-experiment, we found that almost equal amounts of wt
and mutant DI RNAs were immunoprecipitated (data not cation and that deletion of all or part of these sequences
from one or the other terminus of DI RNA may lead toshown), indicating that the mutant DI RNAs were encap-
sidated to almost similar levels. Thus, the inability of the synthesis of altered molar amounts of negative- and posi-
tive-sense RNAs.mutant DI RNAs to be replicated was not due to the loss
of encapsidation signal. The mutant DI RNA with deletion In order to address such a possibility, we generated
two deletion mutant plasmids. Plasmid pDI3*30 encodesof nucleotides 25–30 from the 3*-terminus replicated to
generate low levels of apparently only negative-sense DI a DI RNA in which nucleotides 31 to 45 from the 3*-
terminus were deleted, whereas plasmid pDI5*30 en-RNA (Fig. 4, lane 6). When the 5*-terminal deletion mu-
tants were analyzed, mutant DI RNAs with deletion of codes a DI RNA in which nucleotides 31 to 293 from the
5*-terminus were deleted. In an earlier study, we showednucleotides 1 to 6, 7 to 12, 13 to 18, and 19 to 24 were
not replicated (Fig. 4, lanes 7–10) whereas the mutant that internal sequences from nucleotides 46 and beyond
from the 5*-terminus of DI RNA had little or no effect onDI RNA with deletion of nucleotides 25–30 from the 5*-
terminus replicated to generate low levels of apparently replication (Pattnaik et al., 1995). Thus, the pDI5*30 was
used in this experiment to determine the effect of deletiononly positive-sense DI RNA (Fig. 4, lane 11). Since the
pDI plasmids used in these studies generate only the of nucleotides 31 to 45 from the 5*-terminus of DI RNA
on replication. Cells transfected with the mutant pDI plas-negative-sense DI RNA, it is possible that the negative-
sense DI RNA seen in lane 6 of Fig. 4 may have been mids along with plasmids encoding VSV proteins N, P,
and L were analyzed for replication of the mutant DIsynthesized directly from the transfected plasmid by T7
RNA polymerase as a result of incomplete inhibition of RNAs. Results showed that deletion of nucleotides 31 to
45 from either terminus of DI RNA resulted in significantlyDNA-dependent RNA synthesis by actinomycin D and,
therefore, may not represent the products of RNA replica- lower levels of replication of the mutant DI RNAs (Figs.
5A and 5B, lanes 2) compared to wild-type DI RNA (Figs.tion. However, the absence of the negative-sense RNA
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to 45 at the 5*-terminus. The RNA generated from pDIS
would still maintain 45 nucleotides of complementarity
but would lack the 15-nucleotide-long enhancer se-
quences from nucleotides 31 to 45 at both termini. Analy-
sis of RNA replication products in cells transfected with
these plasmids is shown in Fig. 6. DI3*/5*30 RNA repli-
cated poorly and almost equimolar amounts of both posi-
tive- and negative-sense RNAs were synthesized. The
level of replication of DI3*/5*30 RNA was approximately
5–7% of that of the wild-type DI RNA. The DIS RNA which
contained the 45-nucleotide terminal complementarity
but lacked the sequence at nucleotides 31 to 45 at both
termini did not replicate any better than DI3*/5*30 RNA.
The level of replication of DIS RNA was similar to that
FIG. 5. Replication of DI RNAs containing deletion of the specific of DI3*/5*30 RNA and about 5–7% of that of the wild-type
sequences at either the 3*-terminus (A) or the 5*-terminus (B). BHK-21 DI RNA (Table 1).
cells infected with vTF7-3 were transfected with pDI or mutant pDI These results suggest that the terminal complementar-
plasmids along with plasmids coding for the VSV proteins N, P, and L.
ity of DI RNA does not appear to play a major role inActinomycin D treatment, labeling with [3H]uridine, and subsequent
efficient replication of DI RNA. Rather, a specific se-analysis of RNA were as described in the legend to Fig. 4.
quence corresponding to nucleotides 31 to 45 at the
termini is the determining factor in efficient replication
5A and 5B, lanes 1). In addition, DI3*30 RNA with deletion of DI RNA. In addition, results shown in Fig. 4 suggest
of nucleotides 31 to 45 from the 3*-terminus replicated that nucleotides 25 to 30 at the termini also play a signifi-
to generate a five- to sixfold molar excess of negative- cant role in enhancing DI RNA replication. We suggest
strand RNA over positive-strand RNA (Fig. 5A, lane 2). that nucleotides 25 to 45 at the termini of DI RNA contain
Deletion of corresponding sequences from the 5*-termi- regulatory signal(s) that enhance DI RNA replication sig-
nus of DI RNA, on the other hand, resulted in a five- to nificantly.
sixfold molar excess of positive-strand over negative-
Insertion of the specific sequences from nucleotidesstrand RNA (Fig. 5B, lane 2; Table 1). These results further
25 to 45 into VSV minigenome results in enhancedconfirmed that sequences corresponding to positions 31
replicationto 45 at the termini of the DI particle genome confer
enhanced levels of replication of DI RNA and that dele- We next wanted to determine whether insertion of nt
tion of these sequences from one or the other terminus 25–45 into the 3*-terminus of the VSV genome would
leads to the synthesis of altered molar amounts of nega-
tive- and positive-sense DI RNAs.
Terminal complementarity does not play a major role
in efficient replication of DI RNA
Since the wild-type DI RNA contains 45 nucleotides of
terminal complementarity and replicates efficiently, it has
been proposed that the length of terminal complementar-
ity plays a major role in efficient replication of DI RNA
(Wertz et al., 1994). Therefore, it is possible that the dele-
tion mutants we have analyzed above replicate less effi-
ciently because of disruption or loss of the 45-nucleotide
terminal complementarity. To investigate whether the in-
efficient replication of mutant DI RNAs was due to a lack
of an appropriate length of complementarity or due to
the removal of specific sequences, we constructed two
mutant pDI plasmids. Plasmid pDI3*/5*30 encodes a mu-
tant DI RNA from which the proposed enhancer se-
FIG. 6. Replication of DI RNA mutants that lacked the specific se-quences from nucleotides 31 to 45 at both termini of the
quences but maintained complementarity at the termini. BHK-21 cellsDI RNA have been deleted. A substitution mutant plasmid
in 60-mm plates were infected with vTF7-3 and subsequently trans-
pDIS was generated from pDI3*/5*30 in which comple- fected with plasmids coding for VSV proteins N, P, and L and pDI,
mentary sequences corresponding to nucleotides 46 to pDI3*/5*30, or pDIS. Analysis of replication of RNAs generated from
the pDI plasmids is as described in the legend to Fig. 4.60 at the 3*-terminus of DI RNA replaced nucleotides 31
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result in higher level of replication. A VSV antigenomic
construct p9BN (as described under Materials and Meth-
ods) was used to insert or substitute the complement of
these specific sequences into the 5*-terminus of 9BN
antigenomic RNA. Three different constructs were gener-
ated: p9BN31-45i, in which the complement of the spe-
cific sequences was inserted between nucleotides 30
and 31 at the 5*-terminus of 9BN; p9BN31-45s, in which
the complement of the sequence from nucleotides 31 to
45 was substituted at the corresponding positions at the
5*-terminus of 9BN; and p9BN25-45i, in which the com-
plement sequence corresponding to nucleotides 25 to
45 was inserted between nucleotides 24 and 25 at the
5*-terminus of 9BN.
To determine the levels of replication of the mutant
templates, cells were transfected with plasmids coding
for the VSV proteins N, P, and L and the wild-type p9BN FIG. 7. Replication of a VSV minigenomic analog containing insertion
template or the mutant templates. Replication of RNA in or substitution of the specific sequences. BHK-21 cells in 60-mm plates
were infected with vTF7-3 and subsequently transfected with plasmidsthese cells was analyzed by actinomycin D treatment,
coding for VSV proteins N, P, and L and either p9BN plasmid or itsradiolabeling, immunoprecipitation of replicated RNAs,
derivatives (as shown at the top of lanes 2–5). Cells for the negativeand subsequent electrophoresis in agarose–urea gel.
control (lane 1) were transfected with plasmids as in lane 2 except
Results showed that insertion of the specific sequences that the plasmid encoding the L gene was omitted. At 18 hr post-
31 to 45 resulted in a significant increase in RNA replica- transfection, cells were treated with actinomycin D and subsequently
labeled with [3H]uridine as described previously (Fig. 4). Labeled RNAstion (Fig. 7, lane 3) over that seen with the wild-type 9BN
present in immunoprecipitated nucleocapsids from cell extracts wereRNA (Fig. 7, lane 2). It should be noted that the wild-type
analyzed by agarose–urea gel electrophoresis and detected by fluorog-RNA replicated to produce negative-sense genomic RNA
raphy. Lane 6, containing VSV mRNA, shows the G mRNA (top band),
9BN(0) and barely detectable amounts of positive-sense N mRNA (middle band), and P/M mRNAs (bottom band). [3H]UTP-la-
antigenomic RNA, 9BN(/) (indicated by a dot in lane 2 beled in vitro transcripts from p9BN plasmid are shown in lane 7. The
faint band indicated by an asterisk in lane 7 is the uncleaved primaryof Fig. 7). Upon longer exposure, the antigenomic RNA
transcript which upon autolytic cleavage generates the antigenomicband was visible. Insertion of the sequences resulted in a
9BN RNA (9BN(/)). The genomic-sense 9BN(0) and antigenomic-much higher level (approximately 6-fold) of both negative-
sense 9BN(/) RNA replication products in lanes 2 to 5 are indicated
and positive-sense replication products (Fig. 7, lane 3). on the right. The less clearly visible 9BN(/) RNA in lane 2 (identified
Insertion of nucleotides 25 –45 resulted in a much greater by a dot) is clearly seen in lanes 3 to 5. The RNA band identified
by a filled square in lane 2 is the NDL mRNA, which sometimes isincrease (approximately 15-fold) in RNA replication (Fig.
immunoprecipitated.7, lane 5). This was not surprising considering the fact
that nucleotides 25–30 contribute significantly toward
the upregulation of DI RNA replication. Substitution of
the specific sequences resulted in about 4-fold increase VSV minigenome, the level of replication of the minigen-
ome is upregulated. Studies reported here also showin replication (Fig. 7, lane 4). Thus, these results show
that insertion or substitution of these specific sequences that the efficiency of DI RNA replication is not a function
of the length of complementarity at the termini but ratherinto the VSV minigenome upregulates replication.
is dependent on the presence of these specific se-
quences.DISCUSSION
The DI genomic RNA is a copy-back (or panhandle)
class of DI RNA with 45 nucleotides of terminal comple-In this article, we have identified two distinct regions
at the termini of the VSV DI particle RNA genome that mentarity. The specific sequence (nt 25–45) which is pres-
ent at the 3*-terminus of DI genomic RNA is also presentplay different roles in DI RNA replication. Region I, which
spans nucleotides 1 to 24 at the termini, is absolutely in its complementary form at the 5*-terminus. As a result,
the 3*-terminus (at which replication begins) of both geno-required for replication and contains all the cis-acting
elements necessary and sufficient for DI RNA replication. mic and antigenomic DI RNAs contains these sequences
and therefore this may lead to efficient replication of bothRegion II spans sequences from nucleotides 25 to 45
and contains signal(s) that enhance DI RNA replication. genomic and antigenomic DI RNAs, resulting in synthesis
of high levels and almost equimolar amounts of both RNAs.Unlike the first region, region II is not absolutely required
for replication but plays an important role in the efficient Synthesis of almost equimolar amounts of both genomic
and antigenomic RNAs in DI particle-infected or plasmid-replication of DI RNA. Results further show that when
these sequences are transferred to the 3*-terminus of a transfected cells has been documented previously (Patt-
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naik and Wertz, 1990) as well as in the current study (Figs. tion of these specific sequences into a less efficiently
replicating template resulted in a template that replicated2–6, and Table 1). The 3*-terminus of VSV genomic RNA,
however, does not contain these specific sequences and efficiently (Fig. 7). These data strongly suggest that the
presence of specific sequences (nucleotides 25–45 atmay therefore replicate inefficiently, leading to synthesis of
low levels of full-length antigenomic RNA. The antigenomic the 3*-terminus of the VSV antigenome) rather than com-
plementarity at the termini determines the efficiency ofRNA, on the other hand, does contain these specific se-
quences at its 3*-terminus, which may confer the template replication. Although it is difficult to accommodate these
two divergent interpretations to explain the relative effi-high efficiency in replication, leading to the synthesis of
higher levels of genomic RNA. This may explain previous ciency of replication of VSV and DI particle RNA, it is
possible that most of the RNA templates analyzed byanalyses of full-length RNAs in VSV-infected cells that sug-
gested a much greater abundance (greater than 85–90%) Wertz et al. (1994) that replicated efficiently contain all
or part of these specific sequences. Indeed, the tem-of full-length genomic RNA than of antigenomic RNA
(Schincariol and Howatson, 1972; Simonsen et al., 1979; plates that replicate efficiently contain all or part of these
specific sequences whereas the templates that replicateSoria et al., 1974). In cells transfected with genomic or
antigenomic plasmid constructs under conditions of repli- poorly lack these sequences. Furthermore, our conclu-
sions are consistent with the recent findings for Sendaication, we have also found that the genomic RNA is at
least 10-fold in molar excess over the antigenomic RNA virus (a nonsegmented negative-strand virus) that sug-
gest that the primary sequence at the termini dictates(Fig. 7; and L. Hwang and A. K. Pattnaik, unpublished data).
If the specific sequences at the termini of DI RNA the efficiency of replication of Sendai virus and its DI
particle genome (Tapparel and Roux, 1996). Attempts tofunction in enhancing replication, then by inserting these
sequences into the 3*-terminus of a VSV minigenomic demonstrate the role of terminal complementarity in effi-
cient replication of Sendai virus genome have been un-RNA template, it should be possible to increase the repli-
cation efficiency of the template. Results shown in Fig. successful (Tapparel and Roux, 1996).
Several different hypotheses have been proposed to7 confirm this contention. The presence of these se-
quences at the 3*-terminus of VSV genomic RNAs results explain the replicative advantage of DI RNA over the full-
length homologous viral RNA. The small size of DI RNAin at least 4-fold to as much as 15-fold increase in replica-
tion of these templates. Although the efficiency of replica- which was initially proposed (Huang and Baltimore, 1970)
does not appear to confer any significant replicative ad-tion of both genomic and antigenomic RNAs was signifi-
cantly increased (due to the presence of these specific vantage (Kolakofsky, 1979; Pattnaik et al., 1995). Further-
more, the inability of a majority of DI RNAs to transcribesequences at the 3*-terminus of both RNAs), the molar
ratios of the two RNAs remained almost similar for each also does not appear to influence the replicative advan-
tage since high replication ability of an RNA templateof the constructs tested (approximately 10-fold more ge-
nomic than antigenomic RNA). This is most likely due has recently been shown to be independent of its tran-
scription ability (Calain and Roux, 1995). Our results forto sequence differences at the 3*-terminus of both the
genomic and the antigenomic RNAs. It should be noted VSV and those recently obtained by Tapparel and Roux
(1996) for Sendai virus clearly support the conclusionthat the first eight nucleotides at the 3*-terminus of both
genomic and antigenomic RNAs of VSV are identical, that specific sequences present at the 3*-terminus of the
antigenome dictate the efficiency of replication. In theand therefore differences in sequence beyond this region
may provide another level of complexity to the regulation case of VSV, these sequences are located internally (po-
sitions 25 to 45) whereas in Sendai virus, these se-of synthesis of genomic and antigenomic RNAs. Alterna-
tively, it is possible that the replication promoter at the quences are located within the first 31 nucleotides at the
3*-terminus of the antigenome.3*-terminus of the genome is weakened by its involve-
ment in both transcription and replication compared to The manner by which this specific sequence element
exerts its influence on the efficiency of VSV and DI RNAthe 3*-terminus of the antigenome which is engaged only
in replication. Mutagenic analysis of the 3*-terminus of replication remains speculative at the present time. The
sequence contains the potential P protein binding sitethe VSV genome may provide information as to the nature
and function of the replication signal(s) that is present (3* )UUUGGU(5* ) at nucleotides 31 to 36 (Isaac and
Keene, 1982; Keene et al., 1981). The same sequence isat this terminus.
In a recent report, it was suggested that the extent of also duplicated at nucleotide positions 13 to 18, which
are contained in the minimal signal for replication (nucle-terminal complementarity rather than a specific se-
quence(s) is a major determinant for efficient replication otides 1 to 24) of DI RNAs as well as VSV antigenomic
RNA. Sequence determination and comparison studies(Wertz et al., 1994). However, maintaining the length of
terminal complementarity while deleting these specific with other rhabdoviruses (Giorgi et al., 1983) suggested
that the first hexamer at positions 13 to 18 (which aresequences from an efficiently replicating template re-
sulted in a template (DIS) that replicated about 20-fold present at the 3*-terminus of both genomic and antigeno-
mic RNAs of VSV and DI particles) may be involved inless efficiently (Fig. 6). Conversely, insertion or substitu-
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the plasmid p9BN and for excellent technical assistance. This investi-the initiation of RNA synthesis. Its doubling at the 3*-
gation was supported by Public Health Service Grant AI 34956 fromterminus of the VSV antigenome may explain the en-
the National Institutes of Health.
hanced rate of genomic (negative-sense) RNA synthesis.
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